Levetiracetam Tablet, Film Coated
Product Images NDC 68180-112

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 68180-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01

A text panel showing a formula for calculating the total daily dose of Levetiracetam oral solution based on daily dose in mg/kg/day multiplied by patient weight in kg, divided by the concentration of 100 mg/mL. This formula is used to determine the total milliliters per day required.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02

This image shows a formula used to calculate creatinine clearance (CLcr). It includes adjustment factors for age, weight, serum creatinine, and a multiplication factor for female patients. There is also a formula to adjust CLcr for body surface area (BSA), normalizing to 1.73 square meters.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03

Chemical structure of levetiracetam showing the molecular arrangement of the active ingredient.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04

A bar chart showing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). Each bar is labeled with the number of patients in the group and percentage values above the bars, with two bars marked by an asterisk.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05

Bar chart depicting the percentage of patients across three groups: placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. Patient percentages are shown on the vertical axis with values of 6.3% for placebo, 20.8% for Levetiracetam 1000 mg/day, and 35.2% for Levetiracetam 2000 mg/day.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06

A bar graph comparing the percentage of patients experiencing a specific outcome between placebo and Levetiracetam 3000 mg/day. The placebo group has 14.4% and the Levetiracetam group has 39.4%, with sample sizes of 104 and 180 patients respectively.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07

A bar chart comparing the percentage of patients between placebo (N=97) and Levetiracetam (N=101). The chart shows approximately 19.6% for placebo and 44.6% for Levetiracetam along the y-axis labeled % of Patients.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08

A bar chart comparing the percentage of patients between two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The vertical axis represents the percentage of patients, ranging from 0% to 45%. The chart highlights a higher percentage in the Levetiracetam group.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09

A bar chart comparing the percentage of patients between two groups: Placebo with 45.2% (N=84) and Levetiracetam with 72.2% (N=79). The y-axis represents the percentage of patients, ranging from 0% to 100%.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 10

Levetiracetam Tablets USP 250 mg packaging label by Lupin Pharmaceuticals, Inc. The label indicates 500 tablets, with details including NDC 68180-112-02, pharmacist instructions, storage conditions, and manufacturer information for Lupin Pharmaceuticals in Baltimore, Maryland, and Lupin Limited in India. The label also includes a barcode and QR code for the Medication Guide.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 11

Levetiracetam Tablets USP 500 mg film-coated tablet label from Lupin Pharmaceuticals, Inc. The label indicates 500 tablets per package with storage instructions and pharmacist dispensing warnings. It displays the NDC 68180-113-02, manufacturer Lupin Limited in India, and a QR code linking to the medication guide.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 12

Levetiracetam Tablets USP 750 mg label from Lupin Pharmaceuticals, Inc. The label states 500 tablets in the package, with instructions to dispense a Medication Guide. It includes storage conditions, manufacturer details from Lupin Pharmaceuticals and Lupin Limited, and a barcode. The label also features a QR code linking to the medication guide.*

FDA Label Image

E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 13

Levetiracetam Tablets USP 1000 mg packaging label by Lupin Pharmaceuticals, Inc. The label includes the NDC number 68180-115-02 and indicates a bottle containing 500 tablets. Storage instructions and pharmacist dispensing guidance are provided, along with manufacturer and distributor details for Lupin Pharmaceuticals, Inc. and Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.